7YM8 image
Entry Detail
PDB ID:
7YM8
EMDB ID:
Title:
Cryo-EM structure of Nb29-alpha1AAR-miniGsq complex bound to oxymetazoline
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2022-07-27
Release Date:
2023-07-05
Method Details:
Experimental Method:
Resolution:
2.92 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:alpha1A adrenergic receptor
Chain IDs:B (auth: A)
Chain Length:480
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:miniGsq
Chain IDs:A (auth: B)
Chain Length:246
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:nanobody 29
Chain IDs:C (auth: D)
Chain Length:144
Number of Molecules:1
Biological Source:synthetic construct
Primary Citation
Structural basis of alpha 1A -adrenergic receptor activation and recognition by an extracellular nanobody.
Nat Commun 14 3655 3655 (2023)
PMID: 37339967 DOI: 10.1038/s41467-023-39310-x

Abstact

The α1A-adrenergic receptor (α1AAR) belongs to the family of G protein-coupled receptors that respond to adrenaline and noradrenaline. α1AAR is involved in smooth muscle contraction and cognitive function. Here, we present three cryo-electron microscopy structures of human α1AAR bound to the endogenous agonist noradrenaline, its selective agonist oxymetazoline, and the antagonist tamsulosin, with resolutions range from 2.9 Å to 3.5 Å. Our active and inactive α1AAR structures reveal the activation mechanism and distinct ligand binding modes for noradrenaline compared with other adrenergic receptor subtypes. In addition, we identified a nanobody that preferentially binds to the extracellular vestibule of α1AAR when bound to the selective agonist oxymetazoline. These results should facilitate the design of more selective therapeutic drugs targeting both orthosteric and allosteric sites in this receptor family.

Legend

Protein

Chemical

Disease

Primary Citation of related structures